Published in Eur J Health Econ on October 22, 2013
Cross-national price differences for pharmaceuticals: how large, and why? J Health Econ (2000) 3.79
The impact of price regulation on the launch delay of new drugs--evidence from twenty-five major markets in the 1990s. Health Econ (2005) 3.61
Epidemiology of adult rheumatoid arthritis. Autoimmun Rev (2005) 2.62
Prices and availability of pharmaceuticals: evidence from nine countries. Health Aff (Millwood) (2004) 2.33
Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun (2009) 1.65
Do pharmaceutical prices respond to potential patient out-of-pocket expenses? Rand J Econ (2002) 1.64
The burden of rheumatoid arthritis and access to treatment: uptake of new therapies. Eur J Health Econ (2008) 1.58
Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada. Health Econ (2005) 1.35
The effects of pharmaceutical consumption and obesity on the quality of life in the organization of economic cooperation and development (OECD) countries. Pharmacoeconomics (2004) 0.83
Generic substitution: micro evidence from register data in Norway. Eur J Health Econ (2010) 0.82
Access to primary health care and health outcomes: the relationships between GP characteristics and mortality rates. J Health Econ (2006) 1.01
A panel data study of physicians' labor supply: the case of Norway. Health Econ (2005) 0.96
Wage policy in the health care sector: a panel data analysis of nurses' labour supply. Health Econ (2003) 0.89
Does variation in general practitioner (GP) practice matter for the length of sick leave? A multilevel analysis based on Norwegian GP-patient data. Soc Sci Med (2010) 0.84
Prioritization and patients' rights: analysing the effect of a reform in the Norwegian hospital sector. Soc Sci Med (2009) 0.84
Monitoring prioritisation in the public health-care sector by use of medical guidelines. The case of Norway. Health Econ (2010) 0.82
The impact of different prioritisation policies on waiting times: case studies of Norway and Scotland. Soc Sci Med (2013) 0.81
Between two beds: inappropriately delayed discharges from hospitals. Int J Health Care Finance Econ (2013) 0.77
A low-key social insurance reform--effects of multidisciplinary outpatient treatment for back pain patients in Norway. J Health Econ (2003) 0.75